John C. Martin
2016 - Gilead Sciences
In 2016, John C. Martin earned a total compensation of $10.4M as Executive Chairman at Gilead Sciences, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,014,920 |
|---|---|
| Option Awards | $3,000,063 |
| Salary | $1,737,000 |
| Stock Awards | $3,680,389 |
| Other | $10,000 |
| Total | $10,442,372 |
Martin received $3.7M in stock awards, accounting for 35% of the total pay in 2016.
Martin also received $2M in non-equity incentive plan, $3M in option awards, $1.7M in salary and $10K in other compensation.
Rankings
In 2016, John C. Martin's compensation ranked 474th out of 14,075 executives tracked by ExecPay. In other words, Martin earned more than 96.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 474 out of 14,075 | 97th |
Division Manufacturing | 157 out of 5,489 | 97th |
Major group Chemicals And Allied Products | 38 out of 1,895 | 98th |
Industry group Drugs | 24 out of 1,538 | 98th |
Industry Biological Products, Except Diagnostic Substances | 6 out of 279 | 98th |
Source: SEC filing on March 26, 2018.
Martin's colleagues
We found four more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2016.